CAROLLO, Caterina
 Distribuzione geografica
Continente #
EU - Europa 6.866
NA - Nord America 4.557
AS - Asia 2.997
SA - Sud America 502
AF - Africa 86
OC - Oceania 5
Totale 15.013
Nazione #
US - Stati Uniti d'America 4.418
IT - Italia 4.388
SG - Singapore 873
RU - Federazione Russa 786
CN - Cina 652
BR - Brasile 375
FI - Finlandia 308
HK - Hong Kong 308
IN - India 298
VN - Vietnam 296
UA - Ucraina 256
NL - Olanda 243
DE - Germania 214
BD - Bangladesh 211
PL - Polonia 160
FR - Francia 132
JP - Giappone 115
GB - Regno Unito 108
IE - Irlanda 84
CA - Canada 55
AR - Argentina 45
KR - Corea 38
MX - Messico 37
SE - Svezia 37
IQ - Iraq 31
TR - Turchia 27
ES - Italia 26
RO - Romania 23
CH - Svizzera 21
BE - Belgio 20
EC - Ecuador 19
ZA - Sudafrica 19
UZ - Uzbekistan 18
ID - Indonesia 16
PK - Pakistan 16
CL - Cile 13
CI - Costa d'Avorio 12
CO - Colombia 12
MA - Marocco 12
SA - Arabia Saudita 12
MY - Malesia 11
PY - Paraguay 11
AT - Austria 10
KE - Kenya 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
GR - Grecia 8
HN - Honduras 8
IR - Iran 8
PE - Perù 8
AL - Albania 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
EG - Egitto 7
JM - Giamaica 7
PA - Panama 7
PH - Filippine 7
TN - Tunisia 7
AU - Australia 5
HU - Ungheria 5
KZ - Kazakistan 5
NI - Nicaragua 5
PS - Palestinian Territory 5
SV - El Salvador 5
UY - Uruguay 5
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
GE - Georgia 4
LB - Libano 4
TH - Thailandia 4
AM - Armenia 3
AZ - Azerbaigian 3
BF - Burkina Faso 3
BH - Bahrain 3
IL - Israele 3
LT - Lituania 3
NP - Nepal 3
OM - Oman 3
PR - Porto Rico 3
PT - Portogallo 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
JO - Giordania 2
KH - Cambogia 2
MZ - Mozambico 2
NA - Namibia 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SN - Senegal 2
TW - Taiwan 2
BN - Brunei Darussalam 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
HR - Croazia 1
Totale 15.004
Città #
Ashburn 593
Singapore 535
San Jose 409
Rome 355
Milan 301
Hong Kong 289
Chandler 278
Fairfield 264
Palermo 218
Woodbridge 178
Cagliari 169
Ann Arbor 151
Zgierz 148
Houston 145
Jacksonville 137
Boardman 125
New York 125
Naples 118
Moscow 116
Beijing 115
Wilmington 115
Tokyo 112
Seattle 103
Turin 97
Los Angeles 89
Council Bluffs 85
Medford 85
Cambridge 84
Hanoi 84
Dublin 83
Ho Chi Minh City 83
Faridabad 79
Frankfurt am Main 77
Noida 76
Santa Clara 76
Nanjing 71
Hefei 62
Dallas 60
Lauterbourg 60
Chennai 57
Princeton 51
Bologna 47
Des Moines 47
New Delhi 47
Buffalo 46
Florence 46
Oristano 41
Catania 38
Altamura 37
Dearborn 37
Tulsa 36
Helsinki 34
São Paulo 31
Verona 30
Lawrence 29
Bari 28
Chicago 25
Shenyang 25
The Dalles 25
Ragalna 24
Sassari 24
Venice 24
Jinan 22
Denver 20
Genoa 20
Orem 20
San Diego 19
Amsterdam 18
Munich 18
Brussels 17
Columbus 17
Padova 17
Atlanta 16
Nanchang 16
Rio de Janeiro 16
Da Nang 15
Ludwigshafen am Rhein 15
Novara 15
Oniferi 15
Paris 15
Seongnam 15
Brooklyn 14
Changsha 14
Lappeenranta 14
Messina 14
Phoenix 14
Toronto 14
Ancona 13
Haiphong 13
Mexico City 13
Pescara 13
San Mateo 13
Tashkent 13
Tianjin 13
Abidjan 12
Hebei 12
Johannesburg 12
Monza 12
Ningbo 12
Quartu Sant'Elena 12
Totale 7.752
Nome #
UN ELEVATO RAPPORTO NEUTROFILI-LINFOCITI AUMENTA IL RISCHIO DI EVENTI CARDIOVASCOLARI E DI DECLINO DELLA FUNZIONE RENALE IN UNA COORTE DI PAZIENTI IPERTESI NEFROPATICI 3.326
Ruolo della Ciclofosfamide nel trattamento del Lupus Eritematoso Sistemico in paziente afroamericana con severo incremento degli indici di funzionalità renale. 587
Alterazioni emoreologiche nella sindrome metabolica 539
Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according to the extent. 228
R E L A Z I O N I T R A I N D I C E  D I R E S I S T E N Z A I N T R A PA R E N C H I M A L E R E N A L E E D E N S I TA’ VA S C O L A R E R E T I N I C A VA L U TATA M E D I A N T E A N G I O - O C T 223
Chronic renal failure: oxidative stress, endothelial dysfunction and wine 223
Relationship between blood pressure values and choroidal thicknesses in hypertensive patients 223
Nitric oxide metabolites (nitrite and nitrate) in young patients with recent acute myocardial infarction. 207
Essential hypertension: polymorphonuclear leukocyte integrin profile 206
Pathophysiological and clinical aspects of malnutrition in chronic renal failure 204
Elastase, myeloperoxidase, nitric oxide metabolites and oxidative status in subjects with clinical stable chronic renal failure on conservative treatment 199
Behaviour of carbonyl groups in several clinical conditions: Analysis of our survey 194
Elastasi e parametri dello stress ossidativo nell’ipertensione arteriosa. 193
Relationship of choroidal thickness with pulsatile hemodynamics in essential hypertensive patients 191
Correlation between markers of oxidative status and plasma elastase in juvenile myocardial infarction. 186
Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content at baseline and after activation in essential hypertension 185
Elastasi e stress ossidativo in cardiopatici ischemici sottoposti a test ergometrico 182
Lipid peroxidation and total antioxidant status in juvenile myocardial infarction. 175
Nitric oxide metabolites and oxidative stress in mild essential hypertension 170
Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ content at baseline and after activation in essential hypertension 165
Essential Hypertension: Elastase, Nitric Oxide Metabolites and Oxidative Status. 165
The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey 163
Stress ossidativo in pazienti con sclerodermia: effetti dell’iloprost. 162
Myeloperoxidase in chronic kidney disease. 162
Wine consumption and renal diseases: new perspectives. 161
Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects. 160
Evaluation of nitric oxide production at the initial stage, 3 months and 12 months after juvenile myocardial infarction. 159
Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies 156
Protein oxidation in chronic kidney disease 156
Polymorphonuclear leukocyte integrins in chronic renal failure 156
Emoreologia ed ipertensione 153
Alterazioni funzionali leucocitarie nella malattia ipertensiva 152
BRUGADA PATTERN IN HEROIN ADDICTION: SYNDROME OR PHENOCOPY? 151
Polymorphonuclear leukocyte integrin profile in vascular atherosclerotic disease 151
Wine consumption in the Mediterranean diet: old concepts in a new sight 151
Nitric oxide metabolites (nitrite and nitrate) in several clinical condition 149
Wine, diet and arterial hypertension. 148
Deep venous thrombosis: polymorphonuclear leukocyte integrin profile 148
Prognostic impact of neutrophil-to-lymphocyte ratio and vascular access in patients on chronic hemodialysis 148
MIF rs755622 and IL6 rs1800795 Are Implied in Genetic Susceptibility to End-Stage Renal Disease (ESRD) 147
Assessing the Impact of Inflammation on Erythropoietin Resistance in Hemodialysis: The Role of the NLR. 146
Polymorphonuclear leukocyte: rheology, metabolism and integrin pattern in vascular atherosclerotic disease and in type 2 diabetes mellitus 146
Protein oxidation in mild essential hypertension 146
Relationship Between Subclinical Renal Damage and Maximum Rate of Blood Pressure Variation Assessed by Fourier Analysis of 24-h Blood Pressure Curve in Patients with Essential Hypertension 141
Self-blood pressure monitoring as a tool to increase hypertension awareness, adherence to antihypertensive therapy, and blood pressure control 139
Stress ossidativo e markers di attivazione granulocitaria nell'insufficienza renale cronica in trattamento conservativo e dialitico. 135
Polymorphonuclear leukocyte integrin expression in atherosclerosis and diabetes 135
Early Renal Dysfunction and Reduced Retinal Vascular Density Assessed by Angio-OCT in Hypertensive Patients. 132
Correlations Between Novel Adiposity Indices and Electrocardiographic Evidence of Left Ventricular Hypertrophy in Individuals with Arterial Hypertension 131
Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according to the extent 128
Polymorphonuclear leukocyte integrin profile in vascular atherosclerotic disease with and without type 2 diabetes mellitus. 125
Oxidative stress in juvenile myocardial infarction: evaluation at the initial stage and after 12 months. 122
Moderata assunzione di vino e protezione vascolare 118
Polymorphonuclear leukocyte integrin expression in subjects with type 1 and 2 diabetes mellitus 118
Haemodynamics of primary aldosteronism associated with adrenocortical adenoma: Insights from bioimpedance cardiography measurements 118
Xanthogranulomatous Pyelonephritis: A case Report 117
Sirtuins and Resveratrol in Cardiorenal Diseases: A Narrative Review of Mechanisms and Therapeutic Potential 117
Exploring the Utility of Renal Resistive Index in Critical Care: Insights into ARDS and Cardiac Failure 116
Predictive Biomarkers of Acute Kidney Injury in COVID-19: Distinct Inflammatory Pathways in Patients with and Without Pre-Existing Chronic Kidney Disease 116
Polymorphonuclear leukocyte integrin pattern expression in atherosclerosis and diabetes 114
Leukocyte activation markers and oxidative status in chronic kidney disease. 113
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic Implications 112
Renal Resistive Index and 10-Year Risk of Cardiovascular Disease Predicted by Framingham Risk Score and Pooled Cohort Equations: An Observational Study in Hypertensive Individuals Without Cardiovascular Disease 111
Prevalence of Hypertension in Adolescents: Differences Between 2016 ESH and 2017 AAP Guidelines 109
Correlation Between Hypophosphatemia and Hyperventilation in Critically Ill Patients: Causes, Clinical Manifestations, and Management Strategies 103
Vino e salute 102
Isoechoic Renal Tumors: A Case Report and Literature Review 101
Nitric oxide metabolites in chronic renal failure in conservative and in haemodialysis treatment. 101
The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our survey 98
Mission and One-Year Experience of a Kidney–Heart Outpatient Service: A Patient-Centered Management Model 94
Relationships of Isolated Nocturnal Hypertension with Glomerular Filtration Rate and Albuminuria 88
Silent Inflammation, Loud Consequences: Decoding NLR Across Renal, Cardiovascular and Metabolic Disorders 86
Polymorphonuclear phenotypical expression of CD18, at baseline and after in vitro activation, in several clinical disorders: Revision of our case series 80
Relationship Between 8-iso-prostaglandin-F2α and Predicted 10-Year Cardiovascular Risk in Hypertensive Patients 80
null 80
Sirtuins and Aging: is there a Role for Resveratrol? 80
Relationship Between Renal Resistive Index and Retinal Vascular Density in Individuals with Hypertension 76
Relationship Between Short-Term Blood Pressure Variability and Choroidal–Retinal Thicknesses Assessed by Optical Coherence Tomography in Hypertensive Subjects 72
Novel adiposity indices and their role in identifying left ventricular hypertrophy among hypertensive individuals undergoing echocardiography 52
Nature’s Bioactives in Cardiorenal Syndrome: Polyphenols at the Crossroads—Preclinical Insights into Redox, Inflammation, and Mitochondrial Protection 51
Chloremia Disturbances in Critical Care: A Narrative Review of Pathophysiology, Clinical Impact and Management Strategies 51
Renal Resistive Index and Cardiovascular Events, Cardiovascular Mortality, and All-Cause Mortality: Protocol for a Systematic Review and Meta-Analysis 40
Finerenone in Cardiorenal Disease: A Narrative Review of Molecular Mechanisms, Clinical Evidence, and Emerging Therapeutic Roles 17
Obesity, body adiposity, and intracranial aneurysms: A narrative review of clinical evidence beyond body mass index 14
Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024 11
Effects of Flammable and Non-Flammable Nicotine Products on Kidney Health 7
null 4
null 3
Totale 15.400
Categoria #
all - tutte 40.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022522 14 120 5 28 18 17 27 44 65 56 27 101
2022/2023857 81 124 18 70 92 103 33 68 123 15 73 57
2023/20241.611 66 93 44 91 102 174 147 168 103 216 201 206
2024/20253.349 197 328 408 313 208 207 278 278 286 261 274 311
2025/20266.310 373 192 376 465 492 711 917 654 443 731 490 466
2026/2027180 180 0 0 0 0 0 0 0 0 0 0 0
Totale 15.400